Short description
AI company focused on disease diagnosis to improve patient outcomes and reduce healthcare costs
Description
ClearView Diagnostics has developed deep-learning/AI software to target and identify breast cancer – providing radiologists a quick and inexpensive way to indicate whether or not a woman has breast cancer. Leveraging funding from seed capital, ClearView has been awarded two rounds of National Institutes of Health (NIH) grants to undergo extensive studies in Mexico. In January 2017 the FDA issued a 510(k) for the ClearView cCAD product and the team is moving forward to test in the United States with University Radiology Group, one of the largest, most subspecialized, Board Certified radiology practices in the U.S.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Chicago, Illinois, United States, North America
Founded on
July 15, 2012
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Founders
Dr. Christine Podilchuk, Dr. Richard Mammone